US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 2.3700
  • +0.0100+0.42%
Close Sep 10 16:00 ET
  • 2.3700
  • 0.00000.00%
Post 20:02 ET
6.74MMarket Cap-203P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.06%-5.95M
-11.63%-6.72M
12.80%-24.1M
25.48%-5.41M
0.34%-7.55M
35.93%-5.13M
-25.22%-6.02M
-45.84%-27.64M
-70.41%-7.26M
-76.70%-7.58M
Net income from continuing operations
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.60%-8.61M
Operating gains losses
-4,611.11%-1.7M
-3,630.77%-1.46M
178.20%1.04M
841.72%1.12M
99.76%-1K
94.03%-36K
75.63%-39K
80.16%-1.34M
93.43%-151K
74.91%-421K
Depreciation and amortization
0.00%31K
6.67%32K
-2.31%127K
9.38%35K
-3.13%31K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
-23.81%32K
Other non cash items
--0
-87.76%108K
868.48%891K
450.00%14K
-91.67%1K
0.00%-6K
880.00%882K
-4.17%92K
33.33%-4K
271.43%12K
Change In working capital
-220.11%-418K
-275.86%-925K
624.11%1.62M
457.91%3.21M
-446.35%-2.47M
129.92%348K
-66.56%526K
-78.42%224K
-417.31%-898K
-5.82%712K
-Change in prepaid assets
36.40%-753K
38.17%590K
68.26%-272K
-53.69%301K
-17.12%184K
45.36%-1.18M
-2.51%427K
-298.84%-857K
118.12%650K
-49.32%222K
-Change in payables and accrued expense
-78.13%335K
-1,630.30%-1.52M
75.21%1.89M
288.18%2.91M
-640.82%-2.65M
52.59%1.53M
-91.28%99K
78.09%1.08M
-10,220.00%-1.55M
54.09%490K
Cash from discontinued investing activities
Operating cash flow
-16.06%-5.95M
-11.63%-6.72M
12.80%-24.1M
25.48%-5.41M
0.34%-7.55M
35.93%-5.13M
-25.22%-6.02M
-45.84%-27.64M
-70.41%-7.26M
-76.70%-7.58M
Investing cash flow
Cash flow from continuing investing activities
-85.07%-124K
-81K
-28K
-252.63%-67K
0
0
Net PPE purchase and sale
----
----
-85.07%-124K
---81K
---28K
----
----
-252.63%-67K
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
-85.07%-124K
---81K
---28K
----
----
-252.63%-67K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-151.02%-25K
0
20,321.74%4.65M
4.47M
63.64%-4K
508.33%49K
141K
-100.03%-23K
0
54.17%-11K
Net common stock issuance
--0
--0
--4.17M
--3.96M
--0
--70K
--141K
--0
--0
--0
Net other financing activities
----
----
2,208.70%485K
--510K
63.64%-4K
----
----
0.00%-23K
--0
---11K
Cash from discontinued financing activities
Financing cash flow
-151.02%-25K
--0
20,321.74%4.65M
--4.47M
63.64%-4K
508.33%49K
--141K
-100.03%-23K
--0
54.17%-11K
Net cash flow
Beginning cash position
-54.85%16.82M
-45.42%23.55M
-39.15%43.15M
-51.22%24.58M
-44.53%32.17M
-43.63%37.27M
-39.15%43.15M
367.30%70.9M
-32.97%50.39M
-27.05%58M
Current changes in cash
-17.58%-5.99M
-14.31%-6.72M
29.41%-19.57M
85.90%-1.02M
0.07%-7.58M
36.93%-5.09M
-22.14%-5.88M
-149.73%-27.73M
-69.65%-7.26M
-75.97%-7.59M
Effect of exchange rate changes
900.00%8K
-125.00%-9K
27.59%-21K
-166.67%-6K
47.37%-10K
96.77%-1K
-133.33%-4K
-20.83%-29K
350.00%9K
-18.75%-19K
End cash Position
-66.29%10.85M
-54.85%16.82M
-45.42%23.55M
-45.42%23.55M
-51.22%24.58M
-44.53%32.17M
-43.63%37.27M
-39.15%43.15M
-39.15%43.15M
-32.97%50.39M
Free cash flow
-15.97%-5.96M
-11.63%-6.72M
12.56%-24.23M
24.37%-5.49M
-0.03%-7.58M
36.23%-5.14M
-25.07%-6.02M
-46.05%-27.71M
-69.65%-7.26M
-76.70%-7.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.06%-5.95M-11.63%-6.72M12.80%-24.1M25.48%-5.41M0.34%-7.55M35.93%-5.13M-25.22%-6.02M-45.84%-27.64M-70.41%-7.26M-76.70%-7.58M
Net income from continuing operations 27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.60%-8.61M
Operating gains losses -4,611.11%-1.7M-3,630.77%-1.46M178.20%1.04M841.72%1.12M99.76%-1K94.03%-36K75.63%-39K80.16%-1.34M93.43%-151K74.91%-421K
Depreciation and amortization 0.00%31K6.67%32K-2.31%127K9.38%35K-3.13%31K-8.82%31K-6.25%30K-20.73%130K-5.88%32K-23.81%32K
Other non cash items --0-87.76%108K868.48%891K450.00%14K-91.67%1K0.00%-6K880.00%882K-4.17%92K33.33%-4K271.43%12K
Change In working capital -220.11%-418K-275.86%-925K624.11%1.62M457.91%3.21M-446.35%-2.47M129.92%348K-66.56%526K-78.42%224K-417.31%-898K-5.82%712K
-Change in prepaid assets 36.40%-753K38.17%590K68.26%-272K-53.69%301K-17.12%184K45.36%-1.18M-2.51%427K-298.84%-857K118.12%650K-49.32%222K
-Change in payables and accrued expense -78.13%335K-1,630.30%-1.52M75.21%1.89M288.18%2.91M-640.82%-2.65M52.59%1.53M-91.28%99K78.09%1.08M-10,220.00%-1.55M54.09%490K
Cash from discontinued investing activities
Operating cash flow -16.06%-5.95M-11.63%-6.72M12.80%-24.1M25.48%-5.41M0.34%-7.55M35.93%-5.13M-25.22%-6.02M-45.84%-27.64M-70.41%-7.26M-76.70%-7.58M
Investing cash flow
Cash flow from continuing investing activities -85.07%-124K-81K-28K-252.63%-67K00
Net PPE purchase and sale ---------85.07%-124K---81K---28K---------252.63%-67K--0--0
Cash from discontinued investing activities
Investing cash flow ---------85.07%-124K---81K---28K---------252.63%-67K--0--0
Financing cash flow
Cash flow from continuing financing activities -151.02%-25K020,321.74%4.65M4.47M63.64%-4K508.33%49K141K-100.03%-23K054.17%-11K
Net common stock issuance --0--0--4.17M--3.96M--0--70K--141K--0--0--0
Net other financing activities --------2,208.70%485K--510K63.64%-4K--------0.00%-23K--0---11K
Cash from discontinued financing activities
Financing cash flow -151.02%-25K--020,321.74%4.65M--4.47M63.64%-4K508.33%49K--141K-100.03%-23K--054.17%-11K
Net cash flow
Beginning cash position -54.85%16.82M-45.42%23.55M-39.15%43.15M-51.22%24.58M-44.53%32.17M-43.63%37.27M-39.15%43.15M367.30%70.9M-32.97%50.39M-27.05%58M
Current changes in cash -17.58%-5.99M-14.31%-6.72M29.41%-19.57M85.90%-1.02M0.07%-7.58M36.93%-5.09M-22.14%-5.88M-149.73%-27.73M-69.65%-7.26M-75.97%-7.59M
Effect of exchange rate changes 900.00%8K-125.00%-9K27.59%-21K-166.67%-6K47.37%-10K96.77%-1K-133.33%-4K-20.83%-29K350.00%9K-18.75%-19K
End cash Position -66.29%10.85M-54.85%16.82M-45.42%23.55M-45.42%23.55M-51.22%24.58M-44.53%32.17M-43.63%37.27M-39.15%43.15M-39.15%43.15M-32.97%50.39M
Free cash flow -15.97%-5.96M-11.63%-6.72M12.56%-24.23M24.37%-5.49M-0.03%-7.58M36.23%-5.14M-25.07%-6.02M-46.05%-27.71M-69.65%-7.26M-76.70%-7.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg